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Objective:We report a case series of robotic mitral valve replacement in patients with
severe rheumatic mitral disease.
Methods: From March 2010 to May 2013, a total of 61 patients underwent robotic
cardiac procedures. Robotic procedures were performed using the da Vinci Si surgical
systems (Intuitive Surgical, Inc, Sunnyvale, CA). Seventeen of the patients (27.9%)
underwent robotic mitral valve replacement. Rheumatic disease was the underlying
pathology in all patients. Mean follow up period was 1711 months.
Results:Mean age and Euroscore (%) of the patients were 50.211 and 4.24. Seven
patients (41.1%) had additional cardiac procedure. No operative and hospital mortality
was observed. Mean cross clamp time and cardiopulmonary bypass time were 11835
and 18255 minutes, mean drainage was 440352 ml, mean intubation time was
9.87.2 hours, the rate of patients extubated within 6 hours was 94.1 %, mean
intensive care unit stay time was 3114 hours. Fifteen of the patients (88.2%) were
discharged from the intensive care unit within the postoperative ﬁrst 24 hours. During
the intensive care unit stay one patient (5.8%) needed inotropic support. There was
one early reoperation for bleeding (5.8%). There was one (5.8%) intensive care unit
readmission and one (%5.8) hospital readmission observed. During the late follow up
there was no mortality and no need for reoperation or reintervention.
Conclusions: Robotic mitral valve replacement for severe rheumatic mitral disease is
technically feasible. Early results are encouraging. Patient selection criteria for robotic
mitral valve surgery may be expanded to include valve replacements.Coronary Heart Diseases
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Objective: Coronary slow ﬂow(CSF) is deﬁned as delayed progression and clearence
of injected contrast without any stenosis in coronary arteries. Microvascular
dysfunction, endotel and vasomotor dysfunction and occlusive diseases may have
a role in the pathophysiology. Prolidase is a cytosolic ectopeptidase which has
important role in collagen turnover. Previous studies have demonstrated the rela-
tionship between serum prolidase activity(SPA) and coronary artery disease(CAD). In
our study, we tried to show the relationship between SPA and coronary slow ﬂow.
Material-Methods: Totally 80 patients; 40 of them with coronary slow ﬂow and 40
patients without coronary slow ﬂow are included into the study. Coronary slow ﬂow
diagnosis is performed due to TIMI frame counts in coronary angioraphy. Prolidase
activities of the study population measured via the ELISA method in fasting blood
samples. In statistical analysis, we used independent samples T test, chi-square test
and in correlation analysis spearman rho correlation test was used.
Results: There were no statistically signiﬁcant difference in demographic, clinical and
laboratory properties in two groups, but serum prolidase activity was signiﬁcantly
lower in normal coronary ﬂow patients compared to slow coronary ﬂow patients
(p<0,001).
Conclusion: According to the current literature, our study is the only one that
demonstrated the relation between serum prolidase activity and coronary slow ﬂow
and increase in serum prolidase activity may have a role in coronary slow ﬂow
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coronary artery disease (CAD) and risk for an unfavorable outcome.
Methods: We followed for a mean of 13 years (range 2 to 23) 117 consecutive
patients admitted to coronary care unit with chest pain and transient ST elevation. At
recruitment, all patients underwent intracoronary acetylcholine testing. Patients with
obstructive CAD underwent coronary revascularization within 6 months from
admission. Treatment with calcium antagonists was kept constant during follow-up.
Results: Intracoronary acetylcholine provoked endothelial dysfunction in 39 patients
(group 1). It caused focal coronary spasm in 17 patients and diffusely severe vaso-
constriction (coronary diameters changes of –35+/-11%; range—) in 22 patients. The
remaining 20 patients (group 2) showed mild to normal endothelial function (vaso-
dilatation or mild vasoconstriction with coronary diameters changes of 5+/-1%;
range—). At the end of follow-up, cardiac death occurred in 20 patients and non-fatal
myocardial infarction in 24. The Cox analysis selected left ventricular function,
duration of angina, age, and endothelial dysfunction as multivariate independent
predictors of survival and nonfatal myocardial infarction. Endothelial dysfunction was
the strongest predictor (p<.0001) of major coronary events. Survival of group 1 and 2
was 82% and 95% respectively; survival without infarction was 62% and 83%,
respectively. The extent of obstructive CAD at admission was a predictor of revas-
cularization, but not of survival and nonfatal myocardial infarction. Myocardial
infarction and death occurred most commonly late (4 to 7 years) after diagnosis in
patients previously found with non-obstructive CAD. Recurrent episodes of angina
rarely preceded late coronary events.
Conclusions: Although, as in other categories of CAD, the state of left ventricular
function and the age are major determinants of long-term prognosis, recognition of
clinical markers of endothelial dysfunction predicts an unfavorable course in patients
with variant angina. The extent of CAD does not correlate with endothelial dysfunc-
tion. Intra-coronary acetylcholine may be of value in deﬁning future management
strategies in such patients.
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Objective: The purpose of this study is to investigate the presence of a statistical
association between epicardial fat thickness (EFT) and coronary artery disease (CAD)
and between ﬂow-mediated vasodilation (FMD) and CAD.
Methods: We measured the EFT and FMD in 64 subjects with suspected stable
angina pectoris. The patients were separated into two groups according to their
coronary angiography 34 patients with CAD and 30 patients with normal coronary
arteries (NCA).
Results: EFT was signiﬁcantly higher in the patients with CAD than the NCA group
(6.430.90 vs 5.350.75, p<0.001) while FMD was signiﬁcantly lower in the
patients with CAD than those in the NCA group (6.412.51 vs 8.333.45, p¼0.015).
No signiﬁcant correlation was found between EFT and FMD. After adjustment for
EFT, FMD, age, sex, ejection fraction, glucose and LDL-cholesterol through multi-
variate logistic regression analysis, EFT (odds ratio: 6.325, %95 conﬁdence interval
2.289 – 17.476, p<0.001) and age (odds ratio: 1.093, %95 conﬁdence interval 1.008 –
1.185, p¼0.032) remained signiﬁcant predictors of CAD. A cut-off value of EFT 5.8
predicted the presence of CAD with 77% sensitivity and 70% speciﬁcity.
Conclusion: An echocardiographic EFT assessment is independently associated with
the presence of CAD. Thus, EFT may be helpful in cardiometabolic risk stratiﬁcation
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